Search Results 201-210 of 11393 for anti-TNF drugs

1. Cyclophosphamide (oral route, intravenous route) - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

2. Investigating autoinflammatory epileptic encephalopathies in children - Mayo Clinic

   Drugs & Supplements · Healthy Lifestyle · Mayo ... TNF and IL-6. We are working to develop higher ... anti-seizure medications. Investigative tests and ...

3. Venetoclax (oral route) - Side effects & dosage - Mayo Clinic

   Venetoclax is also used together with other medicines (eg, azacitidine, decitabine, low-dose cytarabine) to treat newly-diagnosed acute myeloid leukemia (AML) ...

4. Anifrolumab-fnia (intravenous route) - Side effects & uses - Mayo Clinic

   If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Abatacept; Adalimumab; Adenovirus ...

5. Gastroenterology and Hepatology - Clinical trials

   In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...

6. 'Virtual clinical trials' may predict success of heart failure drugs

   Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most ...

7. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer - Mayo Clinic

   Drugs used in chemotherapy, such as cisplatin and docetaxel, work in ... anti-TNF\] agents) within 2 weeks prior to registration. * Note: Patients ...

8. A Study to Evaluate Response Markers to Treat Rheumatoid Arthritis - Mayo Clinic

   ... anti-rheumatic medication use. We hypothesize that: Patients responding to antirheumatic medication(s) and their combinations share similar phenotype and/or ...

9. A Study To Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung And Other Cancer Types - Mayo Clinic

   The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...

10. Rituximab-cdxx (intravenous route) - Side effects & uses - Mayo Clinic

    ... medicines (eg, tumor necrosis factor [TNF] antagonist) but did not work well. Rituximab-cdxx injection is used together with steroids to treat ...